46 related articles for article (PubMed ID: 11003880)
21. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
Tonwe-Gold B; Ekouevi DK; Viho I; Amani-Bosse C; Toure S; Coffie PA; Rouet F; Becquet R; Leroy V; El-Sadr WM; Abrams EJ; Dabis F
PLoS Med; 2007 Aug; 4(8):e257. PubMed ID: 17713983
[TBL] [Abstract][Full Text] [Related]
22. High CD4+ T-cells percentage and/or low viral load are predictors of 1-5 years survival in HIV-1 vertically infected Thai children.
Vanprapar N; Chearsakul S; Chokephaibulkit K; Phongsamart W; Lolekha R
J Med Assoc Thai; 2002 Aug; 85 Suppl 2():S690-3. PubMed ID: 12403248
[TBL] [Abstract][Full Text] [Related]
23. Maternal syphilis infection is associated with increased risk of mother-to-child transmission of HIV in Malawi.
Mwapasa V; Rogerson SJ; Kwiek JJ; Wilson PE; Milner D; Molyneux ME; Kamwendo DD; Tadesse E; Chaluluka E; Meshnick SR
AIDS; 2006 Sep; 20(14):1869-77. PubMed ID: 16954728
[TBL] [Abstract][Full Text] [Related]
24. Effects of highly active antiretroviral therapy with nelfinavir in vertically HIV-1 infected children: 3 years of follow-up. Long-term response to nelfinavir in children.
Resino S; Larrú B; Maria Bellón J; Resino R; de José MI; Navarro M; Léon JA; Ramos JT; Mellado MJ; Muñoz-Fernández MA
BMC Infect Dis; 2006 Jul; 6():107. PubMed ID: 16834769
[TBL] [Abstract][Full Text] [Related]
25. Virologic, immunologic, and clinical benefits from early combined antiretroviral therapy in infants with perinatal HIV-1 infection.
Chiappini E; Galli L; Tovo PA; Gabiano C; Gattinara GC; Guarino A; Badolato R; Giaquinto C; Lisi C; de Martino M;
AIDS; 2006 Jan; 20(2):207-15. PubMed ID: 16511413
[TBL] [Abstract][Full Text] [Related]
26. Different rates of disease progression of HIV type 1 infection in Tanzania based on infecting subtype.
Vasan A; Renjifo B; Hertzmark E; Chaplin B; Msamanga G; Essex M; Fawzi W; Hunter D
Clin Infect Dis; 2006 Mar; 42(6):843-52. PubMed ID: 16477563
[TBL] [Abstract][Full Text] [Related]
27. Predictive markers of clinical outcome in vertically HIV-1-infected infants. A prospective longitudinal study.
Resino S; Gurbindo D; Cano JM; Sanchez-Ramón S; Muõz-Fernández MA
Pediatr Res; 2000 Apr; 47(4 Pt 1):509-15. PubMed ID: 10759159
[TBL] [Abstract][Full Text] [Related]
28. Maternal viral load and rate of disease progression among vertically HIV-1-infected children: an international meta-analysis.
Ioannidis JP; Tatsioni A; Abrams EJ; Bulterys M; Coombs RW; Goedert JJ; Korber BT; Mayaux MJ; Mofenson LM; Moye J; Newell ML; Shapiro DE; Teglas JP; Thompson B; Wiener J
AIDS; 2004 Jan; 18(1):99-108. PubMed ID: 15090835
[TBL] [Abstract][Full Text] [Related]
29. Impact of six-week viral load on mortality in HIV-infected Zimbabwean infants.
Mutasa K; Ntozini R; Prendergast A; Iliff P; Rukobo S; Moulton LH; Ward BJ; Humphrey JH;
Pediatr Infect Dis J; 2012 Sep; 31(9):948-50. PubMed ID: 22743826
[TBL] [Abstract][Full Text] [Related]
30. [Prognosis of vertically infected children with HIV].
Bunikowski R; Grosch-Wörner I
Dtsch Med Wochenschr; 1995 Feb; 120(5):160-1. PubMed ID: 7843039
[No Abstract] [Full Text] [Related]
31. Longitudinal assessment of serum urate levels as a marker of HIV disease progression.
Manfredi R; Chiodo F
Int J STD AIDS; 1998 Jul; 9(7):433-4. PubMed ID: 9696204
[No Abstract] [Full Text] [Related]
32. Gender and race do not alter early-life determinants of clinical disease progression in HIV-1 vertically infected children.
European Collaborative Study
AIDS; 2004 Feb; 18(3):509-16. PubMed ID: 15090804
[TBL] [Abstract][Full Text] [Related]
33. Age of biological markers.
Sethi BB
Indian J Psychiatry; 1983 Apr; 25(2):85-6. PubMed ID: 21847261
[No Abstract] [Full Text] [Related]
34. [Prognostic markers of survival in infants younger than 12 month of age vertically infected by human immunodeficiency virus].
Resino S; Jiménez JL; Gurbindo D; Muñoz-Fernández MA
Med Clin (Barc); 1999 Nov; 113(15):561-6. PubMed ID: 10605680
[TBL] [Abstract][Full Text] [Related]
35. Early neurodevelopmental markers predictive of mortality in infants infected with HIV-1.
Llorente A; Brouwers P; Charurat M; Magder L; Malee K; Mellins C; Ware J; Hittleman J; Mofenson L; Velez-Borras J; Adeniyi-Jones S;
Dev Med Child Neurol; 2003 Feb; 45(2):76-84. PubMed ID: 12578232
[TBL] [Abstract][Full Text] [Related]
36. [Primary infection in vertically infected HIV-1 infants: biological characteristics of isolated virus, viral load and CD4 t-lymphocytes].
Resino García S; Jiménez Fuentes JL; Gurbindo Gutiérrez D; Navarro J; Abad ML; Muñoz-Fernández MA
An Esp Pediatr; 1999 Nov; 51(5):469-74. PubMed ID: 10652796
[TBL] [Abstract][Full Text] [Related]
37. Viral studies of mothers with human immunodeficiency virus infection at delivery and their infants in the first 3 days of life.
Sison AV; Brandt CD; Rakusan TA; Wientzen R; Fuccillo DA; Sever JL
Pediatr AIDS HIV Infect; 1996 Oct; 7(5):325-30. PubMed ID: 11361490
[TBL] [Abstract][Full Text] [Related]
38. Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV.
Palombi L; Marazzi MC; Voetberg A; Magid NA
AIDS; 2007 Jul; 21 Suppl 4():S65-71. PubMed ID: 17620755
[TBL] [Abstract][Full Text] [Related]
39. [Clinical manifestations and biological markers in the natural history of HIV-1 infection in vertically infected children. Longitudinal study].
Resino S; Bellón JM; Jiménez JL; Gurbindo D; Muñoz-Fernández MA
An Esp Pediatr; 2000 Feb; 52(2):138-47. PubMed ID: 11003880
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
